Ryoji Goto

Ryoji Goto

Auto-generated profile, based on publicly available information

Ryoji Goto

Advanced Neuroimaging Center, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2023 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
RGRyoji Goto
Ryoji Goto
MKMasanori Kurihara
Masanori Kurihara
MKMasashi Kameyama
Masashi Kameyama
HKHiroki Komatsu
Hiroki Komatsu
MHMasashi Higashino
Masashi Higashino
Atsushi IwataAtsushi Iwata
Atsushi Iwata
Both cerebrospinal fluid (CSF) homovanillic acid (HVA) and striatal dopamine transporter (DAT) binding on single-photon emission computed tomography (SPECT) reflect nigrostriatal dopaminergic function, but studies on the relationship between the two have been limited. It is also unknown whether the reported variance in striatal DAT binding among diseases reflects the pathophysiology or characteristics of the subjects. We included 70 patients with Parkinson’s disease (PD), 12 with progressive supranuclear palsy (PSP), 12 with multiple system atrophy, six with corticobasal syndrome, and nine with Alzheimer’s disease as disease control, who underwent both CSF analysis and 123I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (123I-ioflupane) SPECT. We evaluated the correlation between CSF HVA concentration and the specific binding ratio (SBR) of striatal DAT binding. We also compared the SBR for each diagnosis, controlling for CSF HVA concentration. The correlations between the two were significant in patients with PD (r = 0.34, p = 0.004) and PSP (r = 0.77, p = 0.004). The mean SBR value was the lowest in patients with PSP and was significantly lower in patients with PSP than in those with PD (p = 0.037) after adjusting for CSF HVA concentration. Our study demonstrates that striatal DAT binding correlates with CSF HVA concentration in both PD and PSP, and striatal DAT reduction would be more advanced in PSP than in PD at an equivalent dopamine level. Striatal DAT binding may correlate with dopamine levels in the brain. The pathophysiology of each diagnosis may explain this difference.

1 January 2010 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HAHirokazu Arai
Hirokazu Arai
ANAtsuko Noguchi
Atsuko Noguchi
RGRyoji Goto
Ryoji Goto
TMTakefumi Matsuda
Takefumi Matsuda
HNHatsushi Nakajima
Hatsushi Nakajima
TTTsutomu Takahashi
Tsutomu Takahashi
Premature infants with intrauterine growth restriction (IUGR) are at greater risk for an adverse perinatal outcome. IUGR affects hepatocyte function, but the histopathological changes in the postnatal liver are not well known. We report a male infant with severe IUGR. His mother was transferred to our hospital at 26 weeks of gestation because of preterm labor and severe IUGR. An emergency cesarean section was carried out because of a non-reassuring fetal status. The birth weight of the infant was 332 g. He showed congestive heart failure and marked hepatomegaly from birth. After 1 week, blood examinations showed hyperbilirubinemia with high direct bilirubin. Because of liver dysfunction, he received the minimal total parenteral nutrition for 7 days. After 1 month, he progressively developed ascites and coagulopathy, and died 3 months after birth. Liver autopsy showed diffuse perisinusoidal fibrosis. Fibrosis was also prominent around the central vein. Immunohistochemical study revealed many α-smooth muscle actin-positive cells, which represent activated hepatic stellate cells, and a few transforming growth factor-β1-positive cells in the perisinusoidal fibrotic area. These results indicate that the infant developed chronic (end stage) liver failure by 3 months of age. We excluded congenital infection, metabolic syndrome and citrin deficiency. It is therefore conceivable that intrauterine cardiac failure may be responsible for liver fibrosis. Early detection of liver dysfunction soon after birth is a key to predict the prognosis of severe IUGR in preterm infants.

1 September 2024 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
RSRyosuke Shimasaki
Ryosuke Shimasaki
MKMasanori Kurihara
Masanori Kurihara
KHKeiko Hatano
Keiko Hatano
RGRyoji Goto
Ryoji Goto
KTKenichiro Taira
Kenichiro Taira
Atsushi IwataAtsushi Iwata
Atsushi Iwata
Cerebrospinal fluid (CSF) homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), dopamine and serotonin metabolites, are decreased in Parkinson's disease (PD). Although some reported associations between HVA and striatal dopamine transporter (DAT) or 5-HIAA and cardiac 123I-meta-iodobenzylguanidine (MIBG) findings, respectively, whether these are direct associations remained unknown. We retrospectively reviewed 57 drug-naïve patients with PD who underwent CSF analyses and DAT and cardiac MIBG imaging. Z-score of striatal DAT specific binding ratio (Z-SBR) was measured, and the positivity of MIBG abnormalities were judged by an expert. The mean age was 75.5 ± 8.7 years. Thirty-three were MIBG-positive and 24 were MIBG-negative. 5-HIAA levels were significantly lower in the MIBG-positive group. Logistic regression analysis showed that MIBG positivity was associated with 5-HIAA level (odds ratio = 0.751, p = 0.006) but not with age, sex, and HVA. DAT Z-SBR correlated with both HVA and 5-HIAA. Multiple regression analysis showed that HVA was the only significant variable associated with Z-SBR (t = 3.510, p < 0.001). We confirmed direct associations between 5-HIAA and cardiac MIBG, and between HVA and striatal DAT binding.

1 January 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
RGRyoji Goto
Ryoji Goto
YHYurino Horiuchi
Yurino Horiuchi
HKHaruka Kawakami
Haruka Kawakami
ACAyaka Chikada
Ayaka Chikada
TYTsutomu Yasuda
Tsutomu Yasuda
NANoritoshi Arai
Noritoshi Arai

1 April 2024 in Neuropathology
Verified
Journal Article
Closed access
AAAkira Arakawa
Akira Arakawa
RGRyoji Goto
Ryoji Goto
MHMana Higashihara
Mana Higashihara
YHYuko Hiroyoshi
Yuko Hiroyoshi
ASAyako Shioya
Ayako Shioya
YSYuko Saito
Yuko Saito

10 July 2026 in Science Advances
Verified
Journal Article
Open access
YHYuki Hori
Yuki Hori
HEHironobu Endo
Hironobu Endo
KTKenji Tagai
Kenji Tagai
YKYuko Kataoka
Yuko Kataoka
RGRyoji Goto
Ryoji Goto
THToshiyuki Hirabayashi
Toshiyuki Hirabayashi
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder with motor and cognitive impairments. Whereas motor symptoms are associated with subcortical tau deposits, the mechanisms underlying the cognitive symptoms remain unclear due to heterogeneous and primarily subcortical distribution of pathological tau deposits. Here, we combined tau-PET (tau positron emission tomography) using a high-contrast probe we developed with a normative connectome in 37 patients with PSP and 48 healthy controls. We found that tau deposition sites functionally connected to a common cortical network that could not be derived from atrophy. This network predominantly overlapped with canonical action-mode and frontoparietal networks, which support adaptive, goal-directed behavior. Whereas the extent of primary tau deposition predicted motor symptoms, the normative connectivity strength from tau deposition sites to the identified cortical network explained the severity of cognitive deficits. These findings suggest a previously unknown mechanism that cognitive, but not motor, deficits in PSP arise from remote effects of tau deposition—independent of atrophy—via convergent connectivity to a common cortical network.